These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29570216)
1. Cardiac resynchronization therapy: A comparative analysis of mortality in African Americans and Caucasians. Fontaine JM; Franklin SM; Essilfie G; Ahiable LE Pacing Clin Electrophysiol; 2018 May; 41(5):536-545. PubMed ID: 29570216 [TBL] [Abstract][Full Text] [Related]
2. Mortality in African-Americans Following Cardiac Resynchronization Therapy: A Single Center Experience. Fontaine JM; Franklin SM; Gupta A; Kang CU J Natl Med Assoc; 2016 Feb; 108(1):30-9. PubMed ID: 26928486 [TBL] [Abstract][Full Text] [Related]
3. Addition of angiotensin-converting enzyme inhibitors to beta-blockers has a distinct effect on hispanics compared with african americans and whites with heart failure and reduced ejection fraction: a propensity score-matching study. Eshtehardi P; Pamerla M; Mojadidi MK; Goodman-Meza D; Hovnanians N; Gupta A; Lupercio F; Mazurek JA; Zolty R J Card Fail; 2015 Jun; 21(6):448-56. PubMed ID: 25805065 [TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821 [TBL] [Abstract][Full Text] [Related]
5. Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care. Pamboukian SV; Costanzo MR; Meyer P; Bartlett L; McLeod M; Heroux A J Card Fail; 2003 Apr; 9(2):80-6. PubMed ID: 12751127 [TBL] [Abstract][Full Text] [Related]
6. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259 [TBL] [Abstract][Full Text] [Related]
7. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only. Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878 [TBL] [Abstract][Full Text] [Related]
8. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089 [TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
10. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940 [TBL] [Abstract][Full Text] [Related]
11. Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting. Laish-Farkash A; Bruoha S; Katz A; Goldenberg I; Suleiman M; Michowitz Y; Shlomo N; Einhorn-Cohen M; Khalameizer V Europace; 2017 Aug; 19(8):1357-1363. PubMed ID: 27733457 [TBL] [Abstract][Full Text] [Related]
12. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy. Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186 [TBL] [Abstract][Full Text] [Related]
13. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073 [TBL] [Abstract][Full Text] [Related]
14. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]